New Nordic Healthbrands AB (publ) Six Month Report January - June 2021

FIRST HALF-YEAR 2021

• Net sales amounted to MSEK 268.9 (217,0), an increase of 30.8 percent in local currencies and 23,9 percent in SEK.
• Gross margin decreased to 68.0 percent (70.1).
• EBITDA increased to MSEK 24.6 (11.8).
• Operating profit increased to MSEK 24.1 (11.4).
• Profit after tax for the period increased to MSEK 19.1 (8.7).
• Earnings per share after tax increased to SEK 3.08 (1.40).

New Chief Operating Officer at New Nordic

På ordinarie bolagsstämma i New Nordic Healthbrands AB (publ) den 29 april 2021 beslutades följande

New Nordic Healthbrands AB (publ) Three Month Report January - March 2021

Q1 2021

• Net sales amounted to MSEK 127,8 (112.3), an increase of 13.9 percent. In local currencies, the increase was 21.1 percent.
• Gross margin decreased to 67.0 percent (71.6).
• EBITDA increased to MSEK 13.4 (7.1).
• Operating profit increased to MSEK 13.2 (6.9).
• Profit after tax for the period increased to MSEK 10.4 (5.4).
• Earnings per share after tax increased to SEK 1.68 (0.87).

New Nordic Healthbrands AB (publ) årsredovisning 2020

Kallelse till Årstämma i New Nordic Healthbrands AB (publ)

Aktieägarna i New Nordic Healthbrands AB (publ) kallas härmed till årsstämma.

Plats: Quality Hotel View
Adress: Hyllie Stationstorg 29, 215 32 Malmö
Tid: Torsdagen den 29 april 2021 kl. 10.00 orsdagen den 28 april 2016 kl 10.00.

New Nordic Healthbrands AB has decided to postpone the application for listing on Nasdaq Main Market Stockholm due to the Covid-19 pandemic. The new plan for listing is in 2022.

Following our announcement on February 28, 2020, we confirm that we are preparing for listing on Nasdaq Main Market Stockholm.

However, we have decided to postpone the application until the Covid-19 pandemic has eased.

New Nordic Healthbrands AB (publ) Full Year Report January - December 2020

FULL YEAR 2020

• Net sales amounted to MSEK 450,1 (452,6), a decrease of 0.6 percent. In local currencies, there was an increase of 2.1 percent.
• Gross margin decreased to 68.7 percent (69.7).
• EBITDA decreased to MSEK 25.7 (36.9).
• Operating profit decreased to MSEK 24.9 (36.3).
• Profit after tax for the period decreased to MSEK 17.8 (28.1).
• Earnings per share after tax decreased to SEK 2.87 (4.53).

Q4 2020

• Net sales amounted to MSEK 117.8 (114.4), an increase of 3.0 percent. In local currencies, the increase was 8.4 percent.
• Gross margin decreased to 67.1 percent (67.7).
• EBITDA decreased to MSEK 5.7 (7.1).
• Operating profit decreased to MSEK 5.5 (7.0).
• Profit after tax for the period decreased to MSEK 2.7 (4.6).
• Earnings per share decreased to SEK 0.43 (0.75).

New Nordic Healthbrands AB (publ) Three Month Report January - September 2020

NINE MONTHS 2020

• Net sales amounted to MSEK 332.3 (338.2), an decrease of 1.8 percent. In local currencies, the decrease was 0.1 percent.
• Gross margin decreased to 69.3 percent (70.4).
• EBITDA decreased to MSEK 20.007 (29.8).
• Operating profit decreased to MSEK 19.4 (29.3).
• Profit after tax for the period increased to MSEK 15.1 (23.4).
• Earnings per share after tax increased to SEK 3.23 (4.81).

Six Month Report January - June 2020

SIX MONTHS 2020

• Net sales amounted to MSEK 217.0 (220.2), a decrease of 1.4 percent. In local currencies, the decrease was 1.2 percent.
• Gross margin decreased to 70.1 percent (70.3).
• EBITDA decreased to MSEK 11.8 (15.3).
• Operating profit decreased to MSEK 11.4 (15.0).
• Profit after tax for the period decreased to MSEK 8.6 (12.0).Earnings per share after tax decreased to SEK 1.40 (1.94).

Q2 2020

• Net sales amounted to MSEK 104.8 (116.5), a decrease of 10.1 percent. In local currencies, the decrease was 9.9 percent.
• Gross margin decreased to 68.5 percent (71.0).
• EBITDA decreased to MSEK 4.8 (6.8).
• Operating profit decreased to MSEK 4.5 (6.6).
• Profit after tax for the period decreased to MSEK 3.3 (5.3).
• Earnings per share after tax decreased to SEK 0.53 (0.85).